Antibody-Drug Conjugates in Prostate Cancer: Where Are we?
Auteurs : Mjaess G, Aoun F, Rassy E, Diamand R, Albisinni S, Roumeguère T Jaar : 2023 Journal : Clin Genitourin Cancer
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.
Auteurs : Oderda M, Albisinni S, Benamran D, Calleris G, Ciccariello M, Dematteis A, Diamand R, Descotes JL, Fiard G, Forte V, Giacobbe A, Marquis A, Marra G, Messas A, Muto G, Peltier A, Rius L, Simone G, Roumeguere T, Faletti R, Gontero P Jaar : 2023 Journal : Prostate
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.
Auteurs : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S Jaar : 2023 Journal : World J Urol
Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study.
Auteurs : Windisch O, Benamran D, Dariane C, Favre MM, Djouhri M, Chevalier M, Guillaume B, Oderda M, Gatti M, Faletti R, Colinet V, Lefebvre Y, Bodard S, Diamand R, Fiard G Jaar : 2023 Journal : Eur Urol Open Sci
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Auteurs : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S Jaar : 2023 Journal : Prostate